We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DDMAC’s New Status as Office of New Drug Promotion to Enhance Enforcement
DDMAC’s New Status as Office of New Drug Promotion to Enhance Enforcement
September 24, 2010
The FDA division that focuses on eliminating false and misleading statements in promotional materials for prescription drugs has outgrown its designation and will be reorganized and elevated to an office, according to the director.